Anti-Echinococcus multilocularis effect of total alkaloids of Sophora moorcroftiana in water solution and tablet forms in vitro and in vivo

doi:10.12140/j.issn.1000-7423.2023.01.003

Abstract

Abstract:

Objective To evaluate the anti-Echinococcus multilocularis effect of total alkaloids of Sophora moorcroftiana (TA-SM) in water solution and tablet forms in vitro and in vivo. Methods The protoscolices of E. multilocularis were isolated from the Mongolian gerbils and cultured in a culture flask (10 000 protoscolices/flask). The culture flasks were randomly assigned into the culture medium control group, solvent control group, the albendazole (ABZ) positive control group, the albendazole sulfoxide (ABZ-SO) positive control group, and the low, medium and high concentration groups of TA-SM as water solution groups and as tablet form groups, in which the protoscolices were co-cultured with RPMI 1640 complete medium, or the final concentration of 0.1% dimethyl sulfoxide (DMSO), 10 μg/ml ABZ, 10.60 μg/ml ABZ-SO, or the final concentration of 5 μg/ml (low concentration), 10 μg/ml (medium concentration) and 20 μg/ml (high concentration) of TA-SM in water solution and tablet forms at 37 ℃ and 5% CO₂ for 7 days. The samples collected every day were stained with trypan blue and observed under inverted microscope to check the survival and calculate the survival rate. The relative expression level of alkaline phosphatase (ALP) in the culture supernatant and caspase 3 in protoscolices was detected on the fifth day of co-culture. Fifty-four female Kunming mice were injected with protoscolices of E. multilocularis (0.2 ml/mouse, 10⁴ protoscolices/ml) intraperitoneally and were randomly assigned into the normal saline group, tablet group and water solution group 4 months post-infection. In the water solution group and tablet group, mice were treated with 28 mg/(kg·d) of TA-SM in water solution or tablet forms, respectively, by oral gavage, once a day. In the normal saline group mice were given the same volume of normal saline only. On the 15th, 30th and 60th days of treatment, six mice in each group were randomly selected to dissect, the mass of cyst was weighed, and the rate of cyst inhibition was calculated. The liver tissue sections were prepared, and the pathological changes of the liver tissue were observed using HE staining, the ultrastructure of liver tissue was observed by scanning electron microscope (SEM). One-way ANOVA was used for inter-group comparison, and LSD-t test was used for pairwise comparison. Results On the 7th day of co-culture in vitro, the protoscolices in the medium and in the solvent control groups were oval in shape, and the protoscolices were intact and clear without damage, showing typical invagination. In the ABZ and ABZ-SO and positive control group, the protoscolices became longer, and the sucker was visible, showing the typical eversion type. In the low and medium concentration groups of TA-SM in water solution and tablet forms, the protoscolices were mainly invaginated, and occasionally everted. The morphology of the protoscolices in the high concentration groups of TA-SM in water solution and tablet forms was mostly eversion type. On the 7th day of co-culture in vitro, the survival rates of the protoscolices in the low, medium and high concentration groups of TA-SM in water solution and tablet forms were (34.7 ± 2.75)%, (31.5 ± 10.12)%, (27.6 ± 2.51)% and (30.8 ± 4.15)%, (29.8 ± 8.11)%, (25.2 ± 4.30)%, respectively, with no statistically significant difference between the TA-SM in water solution group and tablet form group (t = 1.36, 0.22, 0.83, all P > 0.05). The survival rates in the TA-SM in water solution group and tablet form group were all lower than that of the medium control group [(78.4 ± 9.68)%] (F = 32.30, 38.53; all P < 0.01) and the solvent control group [(82.7 ± 5.45)%] (F = 55.15, 67.50; all P < 0.01), but there were no significant differences with ABZ positive control group (23.85 ± 19.63)%] (F = 0.53, 0.29; all P > 0.05) or the ABZ-SO positive control group [(18.93 ± 3.08)%] (F =4.44, 3.17; all P > 0.05). On the fifth day of co-culture in vitro, the relative expression levels of ALP in the culture supernatant in the low, medium and high concentration groups of the TA-SM in water solution groups and the tablet form groups, the ABZ and ABZ-SO positive control groups, the medium and solvent control groups were 0.15 ± 0.01, 0.17 ± 0.03, 0.18 ± 0.03 and 0.21 ± 0.04, 0.29 ± 0.04, 0.32 ± 0.04; 0.17 ± 0.01 and 0.15 ± 0.01; 0.15 ± 0.01 and 0.13 ± 0.01, respectively, in which the TA-SM in tablet form groups were higher than medium and solvent control groups, ABZ and ABZ-SO positive control groups (F = 18.49, 22.34, 14.86, 18.06; P < 0.01) and the TA-SM in water solution groups (t = 6.86, 3.78, 5.19; P < 0.05). On the fifth day of co-culture in vitro, the relative expression levels of caspase 3 in protoscolices in the low, medium and high concentration groups of TA-SM in water solution groups and tablet form groups, ABZ and ABZ-SO positive control groups, medium and solvent control groups were 0.14 ± 0.01, 0.13 ± 0.01, 0.14 ± 0.01 and 0.21 ± 0.02, 0.36 ± 0.04, 0.42 ± 0.04; 0.10 ± 0.01 and 0.17 ± 0.01; 0.13 ± 0.01 and 0.10 ± 0.01, respectively, in which the TA-SM in tablet form groups were higher than the medium and solvent control groups, ABZ and ABZ-SO positive control groups (F = 58.97, 69.18, 71.81, 46.77; all P < 0.01) and the TA-SM in water solution group (t = 4.99, 10.24, 10.82; P < 0.01). The results of the in vivo experiment showed that after 60 days of treatment, the cyst inhibition rates of the tablet group and the water solution group were (24.4 ± 4.15)% and (17.2 ± 3.71)%, respectively, with a statistically significant difference between them (t = 3.15, P < 0.05). The HE staining results showed that after 60 days of treatment, the hepatocytes in the saline group were swollen, there were a large number of inflammatory cells infiltrating around, and there were a large number of vacuolar degeneration in the cytoplasm. The morphology of hepatocytes in the water solution group and the tablet group tended to be normal, the inflammatory cells were significantly reduced, and the vacuolar degeneration in the cytoplasm was reduced. SEM results showed that after 15 days of treatment, the typical vesicular structure appeared in the liver tissue lesions of mice in the saline group, while the typical vesicular structures in the liver tissue lesions of mice in the tablet group and the water solution group were significantly reduced. Conclusion TA-SM in water solution and tablet forms have certain suppressive effects on protoscolices of E. multilocularis in vitro and in vivo. The efficacy in vitro test is essentially the same as that of ABZ, and the efficacy of TA-SM in tablet form is better than that in water solution.

Key words: Echinococcus multilocularis, Sophora moorcroftiana, Total alkaloids, Dosage form

CLC Number:

R532.32

DU Tao, HU Chunhui, GAN Xuehui, GAO Pan, ZHANG Fabin. Anti-Echinococcus multilocularis effect of total alkaloids of Sophora moorcroftiana in water solution and tablet forms in vitro and in vivo[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(1): 15-22.

Figures/Tables 4

Fig. 1

Fig. 2

Fig. 3

Fig. 4

References 28

[1]	McManus DP, Zhang WB, Li J, et al. Echinococcosis[J]. Lancet, 2003, 362(9392): 1295-1304.
[2]	Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075-e00018.
[3]	Wang ZH, Wang XM, Liu XQ. Echinococcosis in China, a review of the epidemiology of Echinococcus spp.[J]. EcoHealth, 2008, 5(2): 115-126.
[4]	Nunnari G, Pinzone MR, Gruttadauria S, et al. Hepatic echinococcosis: clinical and therapeutic aspects[J]. World J Gastroenterol, 2012, 18(13): 1448-1458.
[5]	Tan XW, Yu XF, Jiang HJ, et al. Inhibitory effect of xanthohumol on the growth of Echinococcus multilocularis metacestode in the liver of mice[J]. Chin J Parasitol Parasit Dis, 2021, 39(3): 304-310. (in Chinese)
	(谭小武, 俞晓凡, 姜慧娇, 等. 黄腐酚对小鼠肝多房棘球蚴生长的抑制作用[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(3): 304-310.)
[6]	Tian CY, Chen B, Lu S, et al. Toxicity of doxorubicin on Echinococcus granulosus protoscoleces in vitro[J]. Chin J Parasitol Parasit Dis, 2019, 37(5): 571-575, 582. (in Chinese)
	(田春艳, 陈蓓, 卢帅, 等. 阿霉素体外抗细粒棘球蚴原头节作用研究[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(5): 571-575, 582.)
[7]	Qiao SY, Zhou X, Liu CH, et al. Effect of albendazole-loaded vesicles on the vitality of protoscoleces of Echinococcus granulosus[J]. Chin J Parasitol Parasit Dis, 2022, 40(3): 324-329, 336. (in Chinese)
	(乔世源, 周雪, 刘程豪, 等. 阿苯达唑载药囊泡对细粒棘球蚴原头节活性的影响[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(3): 324-329, 336.)
[8]	Lin SM. Sophora japonica in Tibet[J]. Pratacultural Sci, 2002, 19(3): 34. (in Chinese)
	(林少敏. 西藏砂生槐[J]. 草业科学, 2002, 19(3): 34.)
[9]	Luo YP, Zhang Y, Zhang HM, et al. Anti-parasitic effects of water-soluble alkaloid fractions from ethanolic extracts of Sophora moorcroftiana seeds in Caenorhabditis elegans[J]. Chin J Nat Med, 2018, 16(9): 665-673.
[10]	Zhang G, Wang J, Luo Y,et al. In vivo evaluation of the efficacy of Sophora moorcroftiana alkaloids in combination with Bacillus Calmette-Guérin (BCG) treatment for cystic echinococcosis in mice[J]. J Helminthol, 2018, 92(6): 681-686.
[11]	Zhang FB, Hu CH, Cheng SL, et al. The investigation of the effect and mechanism of Sophora moorcroftiana alkaloids in combination with albendazole on echinococcosis in an experimental rats model[J]. Evid Based Complement Alternat Med, 2018, 2018: 3523126.
[12]	Luo YP, Zhang GC, Liu X, et al. Therapeutic and immunoregulatory effects of water-soluble alkaloids E2-a from Sophora moorcroftiana seeds as a novel potential agent against echinococcosis in experimentally protoscolex-infected mice[J]. Vet Res, 2018, 49(1): 100.
[13]	Ma XM, Wan JM, et al. Therapeutic effects of Sophora moorcroftiana alkaloids in combination with albendazole in mice experimentally infected with protoscolices of Echinococcus granulosus[J]. Braz J Med Biol Res, 2007, 40(10): 1403-1408.
[14]	Su G, Yang WK, Meng WB, et al. Anti-proliferation effects of ethanolic extracts from Sophora moorcroftiana seeds on human hepatocarcinoma HepG2 cell line[J]. Nat Prod Res, 2018, 32(12): 1472-1475.
[15]	Yuan RY, Dongzhi ZM, Guo W, et al. Hepatoprotective effect of Sophora moorcroftiana (Benth.) Benth. Ex baker seeds in vivo and in vitro[J]. Drug Chem Toxicol, 2022, 45(6): 2535-2544.
[16]	Hu CH, Yang T, Li YP, et al. Optimization of the purification of total alkaloids from Sophora moorcroftiana seeds[J]. Chin Tradit Pat Med, 2016, 38(10): 2157-2162. (in Chinese)
	(胡春晖, 杨涛, 李永平, 等. 砂生槐子总生物碱纯化工艺的优化[J]. 中成药, 2016, 38(10): 2157-2162.)
[17]	Hu CH, Zhang FB. Optimization of extraction process of total alkaloids from Sophora japonica by box-behnken response surface methodology[J]. Chin Tradit Pat Med, 2016, 38(9): 2063-2066. (in Chinese)
	(胡春晖, 张发斌. Box-Behnken响应面法优化砂生槐子中总生物碱的提取工艺[J]. 中成药, 2016, 38(9): 2063-2066.)
[18]	Hu CH, Dang YJ, Sun MJ, et al. Preparation and quality evaluation of Tibetan medical Sophora moorcroftiana seed extract mini menadhesive tablets[J]. Guid J Tradit Chin Med Pharm, 2018, 24(9): 31-35. (in Chinese)
	(胡春晖, 党云洁, 孙梦娟, 等. 藏药砂生槐子总生物碱生物黏附迷你肠溶片的制备与体内外评价[J]. 中医药导报, 2018, 24(9): 31-35.)
[19]	Gao P, Pan RC, Zhang FB, et al. Therapeutic effects of bioadhesive tablets of total alkaloids from Sophora moorcroftiana and albendazole on secondary alveolar echinococcosis in mice[J]. Chin High Alt Med Biol, 2021, 42(1): 47-52. (in Chinese)
	(高攀, 潘汝翀, 张发斌, 等. 砂生槐子总生物碱生物粘附片与阿苯达唑联合用药治疗继发性小鼠泡球蚴病的疗效[J]. 中国高原医学与生物学杂志, 2021, 42(1): 47-52.)
[20]	Pan RC, Zhang FB, Cheng SL, et al. A study on treatment of secondary hepatic hydatid disease in mice with alkaloids extracted from Sophora moorcroftiana seeds[J]. J Pathog Biol, 2018, 13(3): 254-258. (in Chinese)
	(潘汝翀, 张发斌, 程时磊, 等. 砂生槐生物碱治疗继发性小鼠肝包虫病的实验研究[J]. 中国病原生物学杂志, 2018, 13(3): 254-258.)
[21]	Min H, Hu CH, Hu B, et al. Optimization of extraction technology of total alkaloids from Sophora moorcroftiana based on multi index comprehensive detection and its mechanism of anti-hepatic fibrosis[J]. Guid J Tradit Chin Med Pharm, 2018, 24(10): 14-18. (in Chinese)
	(闵慧, 胡春晖, 胡斌, 等. 基于多指标综合检测优选藏药砂生槐子总生物碱提取工艺及其抗肝纤维化机制研究[J]. 中医药导报, 2018, 24(10): 14-18.)
[22]	Gui XW. Effect of protoscolex of Echinococcus alveolaris on calcification of bone marrow mesenchymal stem cells[D]. Shihezi: Shihezi University, 2020: 4. (in Chinese)
	(桂显伟. 泡状棘球蚴原头节对骨髓间充质干细胞钙化影响的研究[D]. 石河子: 石河子大学, 2020: 4.)
[23]	Zhu JH, Cao DP, Qie YRZ, et al. Effect of Elsholtzia eriostachya in combination with albendazole in treatment of secondary Echinococcus multilocularis metacestode infection in rats[J]. Chin J Parasitol Parasit Dis, 2020, 38(6): 688-694. (in Chinese)
	(朱吉海, 曹得萍, 切羊让中, 等. 藏药黄花香薷联合阿苯达唑治疗大鼠继发性多房棘球蚴感染的疗效研究[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(6): 688-694.)
[24]	Wu Y, Li Z, Xiu AY, et al. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice[J]. Drug Des Devel Ther, 2019, 13: 2667-2676.
[25]	Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview[J]. Ind J Clin Biochem, 2014, 29(3): 269-278.
[26]	Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis[J]. Methods Mol Biol, 2015, 1219: 1-9.
[27]	Araya LE, Soni IV, Hardy JA, et al. Deorphanizing caspase-3 and caspase-9 substrates in and out of apoptosis with deep substrate profiling[J]. ACS Chem Biol, 2021, 16(11): 2280-2296.
[28]	Huang Q, Li F, Liu XJ, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy[J]. Nat Med, 2011, 17(7): 860-866.